{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T05:12:38Z","timestamp":1783746758744,"version":"3.55.0"},"reference-count":32,"publisher":"Tohoku University Medical Press","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.1620\/tjem.2025.j128","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T22:07:02Z","timestamp":1764799622000},"page":"179-187","source":"Crossref","is-referenced-by-count":0,"title":["The Validation of the Effectiveness of Guidelines and the New Reimbursement Scheme for the Prevention of Secondary Hip Fractures in Japan - Current Status of Examination and Medication for Inpatients with Hip Fractures"],"prefix":"10.1620","volume":"269","author":[{"given":"Koki","family":"Abe","sequence":"first","affiliation":[{"name":"Department of Health Administration and Policy, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunio","family":"Tarasawa","sequence":"additional","affiliation":[{"name":"Department of Health Administration and Policy, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiki","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Health Administration and Policy, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyohide","family":"Fushimi","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Informatics, Institute of Science Tokyo Graduate School of Medical and Dental Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Fujimori","sequence":"additional","affiliation":[{"name":"Department of Health Administration and Policy, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"Bliuc, D., Nguyen, N.D., Milch, V.E., Nguyen, T.V., Eisman, J.A.&amp;Center, J.R. (2009)  Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. <i>JAMA<\/i>, 301, 513-521. https:\/\/doi.org\/10.1001\/jama.2009.50","DOI":"10.1001\/jama.2009.50"},{"key":"2","doi-asserted-by":"publisher","unstructured":"Cooper, C., Atkinson, E.J., Jacobsen, S.J., O&apos;Fallon, W.M.&amp;Melton, L.J. 3rd. (1993)  Population-based study of survival after osteoporotic fractures. <i>Am. J. Epidemiol.<\/i>, 137, 1001-1005. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a116756","DOI":"10.1093\/oxfordjournals.aje.a116756"},{"key":"3","doi-asserted-by":"publisher","unstructured":"Cooper, C., Campion, G.&amp;Melton, L.J. 3rd (1992)  Hip fractures in the elderly: a world-wide projection. <i>Osteoporos. Int.<\/i>, 2, 285-289. https:\/\/doi.org\/10.1007\/BF01623184","DOI":"10.1007\/BF01623184"},{"key":"4","doi-asserted-by":"publisher","unstructured":"Fujimori, K., Tarasawa, K.&amp;Fushimi, K. (2021a)  Effectiveness of polymyxin B hemoperfusion for sepsis depends on the baseline SOFA score: a nationwide observational study. <i>Ann. Intensive Care<\/i>, 11, 141. https:\/\/doi.org\/10.1186\/s13613-021-00928-z","DOI":"10.1186\/s13613-021-00928-z"},{"key":"5","doi-asserted-by":"publisher","unstructured":"Fujimori, K., Tarasawa, K.&amp;Fushimi, K. (2021b)  Effects of Polymyxin B Hemoperfusion on Septic Shock Patients Requiring Noradrenaline: Analysis of a Nationwide Administrative Database in Japan. <i>Blood Purif.<\/i>, 50, 560-565. https:\/\/doi.org\/10.1159\/000513213","DOI":"10.1159\/000513213"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Gadallah, N.&amp;El Miedany, Y. (2022)  Operative secondary prevention of fragility fractures: national clinical standards for fracture liaison service in Egypt\u2014an initiative by the Egyptian Academy of Bone Health. <i>Egyptian Rheumatology and Rehabilitation<\/i>, 49, 11. https:\/\/doi.org\/10.1186\/s43166-022-00111-7","DOI":"10.1186\/s43166-022-00111-7"},{"key":"7","doi-asserted-by":"publisher","unstructured":"Gondo, G., Shin, J.H., Kunisawa, S.&amp;Imanaka, Y. (2025)  Impact of the guidance on fracture Liaison Services and the introduction of a new fee for secondary fracture prevention in Japan: Implementation of secondary fracture prevention during hospitalization for fragility fractures. <i>Osteoporos. Int.<\/i>, 36, 235-244. https:\/\/doi.org\/10.1007\/s00198-024-07269-0","DOI":"10.1007\/s00198-024-07269-0"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez-Quevedo, D., Rubia-Ortega, C., Sanchez-Delgado, A., Moriel-Garceso, D., Sanchez-Siles, J.M., Bravo-Bardaji, M., Garcia-de-Quevedo, D.&amp;Tamimi, I. (2024)  Secondary osteoporosis prevention: three-year outcomes from a Fracture Liaison Service in elderly hip fracture patients. <i>Aging Clin. Exp. Res.<\/i>, 36, 103. https:\/\/doi.org\/10.1007\/s40520-024-02761-3","DOI":"10.1007\/s40520-024-02761-3"},{"key":"9","doi-asserted-by":"publisher","unstructured":"Hagino, H., Sawaguchi, T., Endo, N., Ito, Y., Nakano, T.&amp;Watanabe, Y. (2012)  The risk of a second hip fracture in patients after their first hip fracture. <i>Calcif Tissue Int<\/i>, 90, 14-21. https:\/\/doi.org\/10.1007\/s00223-011-9545-6","DOI":"10.1007\/s00223-011-9545-6"},{"key":"10","doi-asserted-by":"publisher","unstructured":"Hayashida, K., Murakami, G., Matsuda, S.&amp;Fushimi, K. (2021)  History and Profile of Diagnosis Procedure Combination (DPC): Development of a Real Data Collection System for Acute Inpatient Care in Japan. <i>J. Epidemiol.<\/i>, 31, 1-11. https:\/\/doi.org\/10.2188\/jea.JE20200288","DOI":"10.2188\/jea.JE20200288"},{"key":"11","unstructured":"Japan Osteoporosis Society; The Japanese Society for Bone and Mineral Research, and Japan Osteoporosis Foundation (2015) Guidelines for Prevention and Treatment of Osteoporosis 2015 (in Japanese). Sanposha Publishing Co Ltd, Tokyo."},{"key":"12","unstructured":"Japanese Orthopaedic Association (JOA) (2021) Clinical Practice Guidelines on the Management of Hip Fractures (in Japanese). Nankodo, Tokyo, Japan."},{"key":"13","doi-asserted-by":"publisher","unstructured":"Kates, S.L.&amp;Miclau, T. (2022)  The fracture liaison service: its history, current state, how it works, and future directions. <i>OTA Int.<\/i>, 5, e192. https:\/\/doi.org\/10.1097\/OI9.0000000000000192","DOI":"10.1097\/OI9.0000000000000192"},{"key":"14","doi-asserted-by":"publisher","unstructured":"Keshishian, A., Boytsov, N., Burge, R., Krohn, K., Lombard, L., Zhang, X., Xie, L.&amp;Baser, O. (2017)  Examining the Effect of Medication Adherence on Risk of Subsequent Fracture Among Women with a Fragility Fracture in the U.S. Medicare Population. <i>J Manag. Care Spec. Pharm.<\/i>, 23, 1178-1190. https:\/\/doi.org\/10.18553\/jmcp.2017.17054","DOI":"10.18553\/jmcp.2017.17054"},{"key":"15","doi-asserted-by":"publisher","unstructured":"Klop, C., Gibson-Smith, D., Elders, P.J., Welsing, P.M., Leufkens, H.G., Harvey, N.C., Bijlsma, J.W., van Staa, T.P.&amp;de Vries, F. (2015)  Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000-2010. <i>Osteoporos. Int.<\/i>, 26, 1919-1928. https:\/\/doi.org\/10.1007\/s00198-015-3098-x","DOI":"10.1007\/s00198-015-3098-x"},{"key":"16","doi-asserted-by":"publisher","unstructured":"McLellan, A.R., Gallacher, S.J., Fraser, M.&amp;McQuillian, C. (2003)  The fracture liaison service: success of a program for the evaluation and management of patients with osteoporotic fracture. <i>Osteoporos. Int.<\/i>, 14, 1028-1034. https:\/\/doi.org\/10.1007\/s00198-003-1507-z","DOI":"10.1007\/s00198-003-1507-z"},{"key":"17","unstructured":"Ministry of Health, Labour and Welfare of Japan(2022) Overview of the medical fee revision for fiscal year 2022. (in Japanese).https:\/\/www.mhlw.go.jp\/content\/12400000\/000912336.pdf [<i>Accessed<\/i>: October 12, 2024]."},{"key":"18","doi-asserted-by":"publisher","unstructured":"Miyazaki, D., Tarasawa, K., Fushimi, K.&amp;Fujimori, K. (2023)  Risk factors of readmission and the impact of outpatient management in heart failure patients: A national study in Japan. <i>ESC Heart Fail<\/i>, 10, 3299-3310. https:\/\/doi.org\/10.1002\/ehf2.14498","DOI":"10.1002\/ehf2.14498"},{"key":"19","doi-asserted-by":"publisher","unstructured":"Mori, Y., Tarasawa, K., Tanaka, H., Mori, N., Kanabuchi, R., Fushimi, K., Aizawa, T.&amp;Fujimori, K. (2025)  Rheumatoid arthritis increases complication risks in elderly hip fracture patients: A Japanese nationwide medical claims database study. <i>Mod. Rheumatol.<\/i>, 35, 287-293. https:\/\/doi.org\/10.1093\/mr\/roae088","DOI":"10.1093\/mr\/roae088"},{"key":"20","doi-asserted-by":"publisher","unstructured":"Nakatoh, S., Fujimori, K., Ishii, S., Tamaki, J., Okimoto, N., Ogawa, S.&amp;Iki, M. (2021)  Insufficient persistence to pharmacotherapy in Japanese patients with osteoporosis: an analysis of the National Database of Health Insurance Claims and Specific Health Checkups in Japan. <i>Arch. Osteoporos.<\/i>, 16, 131. https:\/\/doi.org\/10.1007\/s11657-021-00993-8","DOI":"10.1007\/s11657-021-00993-8"},{"key":"21","doi-asserted-by":"publisher","unstructured":"Nakatoh, S., Fujimori, K., Tamaki, J., Okimoto, N., Ogawa, S.&amp;Iki, M. (2020)  Insufficient increase in bone mineral density testing rates and pharmacotherapy after hip fracture in Japan. <i>J. Bone Miner. Metab.<\/i>, 38, 589-596. https:\/\/doi.org\/10.1007\/s00774-020-01093-2","DOI":"10.1007\/s00774-020-01093-2"},{"key":"22","doi-asserted-by":"publisher","unstructured":"Nymark, T., Lauritsen, J.M., Ovesen, O., Rock, N.D.&amp;Jeune, B. (2006)  Short time-frame from first to second hip fracture in the Funen County Hip Fracture Study. <i>Osteoporos. Int.<\/i>, 17, 1353-1357. https:\/\/doi.org\/10.1007\/s00198-006-0125-y","DOI":"10.1007\/s00198-006-0125-y"},{"key":"23","doi-asserted-by":"publisher","unstructured":"Ota, T., Harada, A., Washimi, Y., Okuizumi, H.&amp;Arahata, Y. (2005)  The economic and social costs of geriatric diseases. <i>Nihon Ronen Igakkai Zasshi<\/i>, 42, 645-647. https:\/\/doi.org\/10.3143\/geriatrics.42.645","DOI":"10.3143\/geriatrics.42.645"},{"key":"24","doi-asserted-by":"publisher","unstructured":"Patel, R., Judge, A., Johansen, A., Javaid, M.K., Griffin, X.L., Chesser, T., Griffin, J., Marques, E.M.R., Group, R.S., Ben-Shlomo, Y.&amp;Gregson, C.L. (2024)  Following hip fracture, hospital organizational factors associated with prescription of anti-osteoporosis medication on discharge, to address imminent refracture risk: a record-linkage study. <i>J. Bone Miner. Res.<\/i>, 39, 1071-1082. https:\/\/doi.org\/10.1093\/jbmr\/zjae100","DOI":"10.1093\/jbmr\/zjae100"},{"key":"25","doi-asserted-by":"publisher","unstructured":"Roux, C.&amp;Briot, K. (2017)  Imminent fracture risk. <i>Osteoporos Int<\/i>, 28, 1765-1769. https:\/\/doi.org\/10.1007\/s00198-017-3976-5","DOI":"10.1007\/s00198-017-3976-5"},{"key":"26","doi-asserted-by":"publisher","unstructured":"Ruggiero, C., Zampi, E., Rinonapoli, G., Baroni, M., Serra, R., Zengarini, E., Baglioni, G., Duranti, G., Ercolani, S., Conti, F., Caraffa, A., Mecocci, P.&amp;Brandi, M.L. (2015)  Fracture prevention service to bridge the osteoporosis care gap. <i>Clin. Interv. Aging<\/i>, 10, 1035-1042. https:\/\/doi.org\/10.2147\/CIA.S76695","DOI":"10.2147\/CIA.S76695"},{"key":"27","doi-asserted-by":"publisher","unstructured":"Salari, N., Ghasemi, H., Mohammadi, L., Behzadi, M.H., Rabieenia, E., Shohaimi, S.&amp;Mohammadi, M. (2021)  The global prevalence of osteoporosis in the world: a comprehensive systematic review and meta-analysis. <i>J. Orthop. Surg. Res.<\/i>, 16, 609. https:\/\/doi.org\/10.1186\/s13018-021-02772-0","DOI":"10.1186\/s13018-021-02772-0"},{"key":"28","doi-asserted-by":"publisher","unstructured":"Solomon, D.H., Johnston, S.S., Boytsov, N.N., McMorrow, D., Lane, J.M.&amp;Krohn, K.D. (2014)  Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011. <i>J. Bone Miner. Res.<\/i>, 29, 1929-1937. https:\/\/doi.org\/10.1002\/jbmr.2202","DOI":"10.1002\/jbmr.2202"},{"key":"29","doi-asserted-by":"publisher","unstructured":"Takusari, E., Sakata, K., Hashimoto, T., Fukushima, Y., Nakamura, T.&amp;Orimo, H. (2021)  Trends in Hip Fracture Incidence in Japan: Estimates Based on Nationwide Hip Fracture Surveys From 1992 to 2017. <i>JBMR Plus<\/i>, 5, e10428. https:\/\/doi.org\/10.1002\/jbm4.10428","DOI":"10.1002\/jbm4.10428"},{"key":"30","doi-asserted-by":"publisher","unstructured":"Tarasawa, K., Fujimori, K.&amp;Fushimi, K. (2020)  Recombinant Human Soluble Thrombomodulin Contributes to a Reduction In-Hospital Mortality of Acute Cholangitis with Disseminated Intravascular Coagulation: A Propensity Score Analyses of a Japanese Nationwide Database. <i>Tohoku J. Exp. Med.<\/i>, 252, 53-61. https:\/\/doi.org\/10.1620\/tjem.252.53","DOI":"10.1620\/tjem.252.53"},{"key":"31","doi-asserted-by":"publisher","unstructured":"Wang, X., Li, C., He, Y., Wang, T., Zhang, H., Ma, Z., Ma, H.&amp;Zhao, H. (2020)  Anti-osteoporosis medication treatment pattern after osteoporotic fracture during 2010-2016 in Fujian, China. <i>Arch. Osteoporos.<\/i>, 15, 134. https:\/\/doi.org\/10.1007\/s11657-020-00798-1","DOI":"10.1007\/s11657-020-00798-1"},{"key":"32","doi-asserted-by":"publisher","unstructured":"Yamamoto, N., Sawaguchi, T., Matsushita, T., Katoh, N., Arai, H., Shirahama, M., Endo, N., Hagino, H., Mori, S., Teramoto, T., Ookuro, M., Hiraoka, M.&amp;Takahashi, H.E. (2024)  Fragility Fracture Network-Japan: The challenge of establishment of a national hip fracture database and successful achievement of nationwide health system change for hip fracture care in Japan. <i>Injury<\/i>, 55, 111452. https:\/\/doi.org\/10.1016\/j.injury.2024.111452","DOI":"10.1016\/j.injury.2024.111452"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/269\/2\/269_2025.J128\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T04:29:33Z","timestamp":1783744173000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/269\/2\/269_2025.J128\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.2025.j128","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"2025.J128"}}